Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16648503

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2006 May 1
First author
Hanna N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2006 Nov 10;24(32):5175; author reply 5175-6. doi: 10.1200/JCO.2006.07.5531.
    note
    Source null
    related pmid
    17093285
    relationship
    Comment in

Authors and identifiers

  1. name
    Hanna N
    type
    Author
  2. name
    Bunn PA Jr
    type
    Author
  3. name
    Langer C
    type
    Author
  4. name
    Einhorn L
    type
    Author
  5. name
    Guthrie T Jr
    type
    Author
  6. name
    Beck T
    type
    Author
  7. name
    Ansari R
    type
    Author
  8. name
    Ellis P
    type
    Author
  9. name
    Byrne M
    type
    Author
  10. name
    Morrison M
    type
    Author
  11. name
    Hariharan S
    type
    Author
  12. name
    Wang B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hanna N
    type
    Author
  2. name
    Bunn PA Jr
    type
    Author
  3. name
    Langer C
    type
    Author
  4. name
    Einhorn L
    type
    Author
  5. name
    Guthrie T Jr
    type
    Author
  6. name
    Beck T
    type
    Author
  7. name
    Ansari R
    type
    Author
  8. name
    Ellis P
    type
    Author
  9. name
    Byrne M
    type
    Author
  10. name
    Morrison M
    type
    Author
  11. name
    Hariharan S
    type
    Author
  12. name
    Wang B
    type
    Author
bibliography ids
  1. nci-bib-47198d37bfe47eb0d6b56619
book metadata
content sha256
daba766dbb9f094705831394db6fb537d99d3a377a4315a841dc2f91d1ec59a4
document type
citation
dois
  1. 10.1200/JCO.2005.04.8595
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:16648503
immutable id
pubmed:16648503@daba766dbb9f094705831394db6fb537d99d3a377a4315a841dc2f91d1ec59a4
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
13
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2038-43
volume
24
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2006 Nov 10;24(32):5175; author reply 5175-6. doi: 10.1200/JCO.2006.07.5531.
    note
    Source null
    related pmid
    17093285
    relationship
    Comment in
outcomes validated
false
pmid
16648503
provenance
batch id
19fb2de9a00882c94e86
provider
NCBI PubMed ESummary
record sha256
d29fb129afaff701d7f465949a8d5f41f871032a2cd9e3e424cdf4ce934aa07a
response sha256
4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
retrieved at
2026-09-09T23:46:06.810486+00:00
publication date
display
2006 May 1
precision
day
year
2006
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/16648503/
title
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.

Preserved source evidence · Not medical advice